News

Press Releases

Asuragen Portfolio Expansion Continues with Launch of AmplideX® PCR/CE SMN1/2 Kit
Asuragen NGS System for Streamlined Detection of RNA Lung Cancer Variants Demonstrates Superior Performance in Multisite Evaluation
Asuragen Announces Launch of AmplideX® PCR/CE HTT Kit
Asuragen Launches Assay to Aid in the Diagnosis of Myotonic Dystrophy Type I (DM1)
Asuragen Announces Health Canada Approval of the QuantideX® qPCR BCR-ABL IS Kit
Asuragen to Present at 2018 Association for Molecular Pathology (AMP) Annual Meeting
New laboratory screening test for fragile X syndrome shortly after birth now ready for pivotal North Carolina Early Check clinical study
Asuragen Announces New Commercial Leadership Appointment
Asuragen to Present at 2018 American Society of Human Genetics Annual Meeting
Asuragen to Host Panel at Upcoming World Clinical Biomarkers & Companion Diagnostic Summit

About

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close